Renfu Pharmaceutical: The company's stock will be subject to other risk warnings and the stock will be suspended on December 16th.

Renfu Pharmaceuticals announcement, the company received a "Notice of Administrative Penalty Pre-notification" issued by the Hubei branch of the China Securities Regulatory Commission on December 12, 2025. According to relevant regulations, the company's stock will be subject to other risk warnings. The company's stock will be suspended for one day on December 15, 2025, and other risk warnings will be implemented starting from December 16, 2025. After the implementation, the A-share abbreviation will be changed to "ST Renfu", with a daily price limit of 5%.